A message from Trust Chair Kathy Doran and Chief Executive Joan Spencer

Today we launch Our Strategy 2026 – 2031, which sets out our priorities and ambitions for the next five years. It builds on the strong foundations of our 2021 – 2026 strategy and reaffirms our commitment to exceptional, compassionate cancer care for the people and communities we serve.

As you might expect, our strategy explains how we plan to make sure The Clatterbridge Cancer Centre continues to deliver outstanding care, visionary research and digital innovation in a collaborative and inclusive way and that we are a great place to work.

As a leading specialist cancer centre, our role extends beyond the care we provide to people referred to us. We can use our expertise, partnerships and research strengths to improve cancer care at every stage: from early symptoms and diagnosis through to treatment, recovery, life after cancer, and end-of-life care for people whose disease reaches that stage.

Our mission is to transform the lives of people living with and beyond cancer by delivering compassionate, world-class care and advancing groundbreaking research in collaboration with those we serve.

We will do this in partnership with patients, carers and the people who matter to them, working closely with colleagues across health and social care, research partners, universities and local communities. We will also be socially responsible, taking proactive action on health inequalities, environmental sustainability and the wider challenges that shape people’s health and wellbeing.

Our five strategic priorities make this clear:

Be Outstanding: Deliver excellent, person-centred cancer care that is safe, effective, accessible and continuously improving.

Be Collaborative: Work with partners and lead system-wide change to improve cancer pathways, reduce inequalities and build more resilient services.

Be a Great Place to Work: Create an inclusive, supportive and high-performing workplace where staff can thrive and deliver their best for patients.

Be Visionary Research Leaders: Accelerate and expand research, trials and innovation so more people can benefit from tomorrow’s treatments today and achieve improved outcomes.

Be Digital: Use digital technology, data and innovation to transform and improve care, access, productivity, and patient experience.

This strategy has been shaped by feedback from staff, patients and partner organisations on the draft version we shared in May. We want to say a huge thank-you to everyone who took the time to share your views and ideas, helping us make sure it reflects the right ambitions and priorities.

Over the next five years, we will turn this strategy into reality through robust business planning, clear goals and well-planned delivery programmes. Together, we will achieve our ambitions and ensure The Clatterbridge Cancer Centre continues to be a beacon of excellence in compassionate cancer care.